血清SAA、IL-12及IL-6水平在儿童手足口病病情中的评估价值

doi:10.3969/j.issn.1671-7171.2024.08.016

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1273 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】 To explore the value of combined detection of serum amyloid A (SAA), interleukin-12 (IL-12), and interleukin-6 (IL-6) levels in assessing the severity of hand, foot, and mouth disease (HFMD) in children.【Methods】 A total of 100 HFMD children were selected as the observation group, and 100 healthy children undergoing physical examination in the same period served as the control group. The children in the observation group were divided into mild (n=46), severe (n=34), and critical (n=20) groups based on the severity of their conditions. Serum levels of SAA, IL-12, and IL-6 in children with HFMD and healthy children were compared. The diagnostic value of these serum levels for HFMD was analyzed using the receiver operating characteristic (ROC) curves. The data of children with different severity levels were compared, and the correlation between serum levels of SAA, IL-12, and IL-6 and disease severity was analyzed.【Results】 The levels of serum SAA, IL-12, and IL-6 in the observation group were significantly higher than those in the control group (P<0.05). ROC analysis showed that the areas under the curve (AUC) for serum SAA, IL-12, and IL-6 levels were 0.873, 0.843, and 0.840, respectively, with sensitivities of 0.870, 0.820, and 0.830, respectively (all P<0.05). The levels of serum SAA, IL-12, and IL-6 in the critical group were significantly higher than those in the mild and severe groups, and their levels in the severe group were significantly higher than those in the mild group (P<0.05). Correlation analysis showed that the levels of serum SAA, IL-12, and IL-6 were positively correlated with the severity of the disease (all P<0.05).【Conclusion】 The levels of serum SAA, IL-12, and IL-6 can predict the severity of HFMD in children. The higher these levels detected, the more severe condition for the child.

Key words： Hand, Foot and Mouth Disease Serum Amyloid A Protein Interleukin-12 Interleukin-6 Child

Received: 09 June 2023

PACS:

R725.125.7

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.08.016 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I8/1175

[1] 崔金朝, 聂陶然, 任敏睿,等. 2008－2018年中国5岁及以下儿童手足口病死亡病例流行病学特征[J].中华流行病学杂志, 2020, 41(7):1041-1046.
[2] 王雅婷, 朋文佳, 苏华林,等. 2011－2018年中国手足口病发病的时空特征及影响因素研究[J].中华流行病学杂志, 2022, 43(10):1562-1567.
[3] 于季红, 赵秀梅. SAA、PCT及WBC对肠道病毒71型感染手足口病患儿的诊断价值[J].中国现代医学杂志, 2020, 30(18):22-26.
[4] 马富强, 苟尕虎, 张晶晶. 血清CK-MB、IL-6、PA水平与小儿手足口病严重程度及预后的关系分析[J].检验医学与临床, 2021, 18(18):2634-2637.
[5] 卫生部手足口病临床专家组. 肠道病毒71型(EV71)感染重症病例临床救治专家共识[J].中华儿科杂志, 2011, 49(9):675-678.
[6] 于秋丽, 刘莹莹, 赵文娜,等. 河北省2013－2017年其他肠道病毒手足口病重症和死亡病例流行病学和病原特征分析[J].中华流行病学杂志, 2020, 41(7):1054-1057.
[7] 张荣, 杜健, 薛智民. 不同病情手足口病患儿血清IL-1β、TNF-α、IL-6、IL-10水平变化及其临床意义研究[J].中国妇幼保健, 2020, 35(18):3491-3493.
[8] 郑文博, 王伟. 血清淀粉样蛋白A、C反应蛋白与免疫球蛋白联合检测对手足口病的早期诊断价值[J].陕西医学杂志, 2022, 51(8):1013-1015.
[9] 张诗海, 孙丽. 血清淀粉样蛋白A和急性时相蛋白C反应蛋白在不同病毒所致手足口病患儿中的诊断效能[J].医学综述, 2020, 26(16):3313-3316.
[10] WU F, HOU X Q, SUN R R, et al. The predictive value of joint detection of serum amyloid protein A, PCT, and Hs-CRP in the diagnosis and efficacy of neonatal septicemia[J].Eur Rev Med Pharmacol Sci,2019, 23(13):5904-5911.
[11] 杨世明, 丁莉, 沈瑛,等. 200例手足口病患儿临床表现及其实验室诊断[J].中华医院感染学杂志, 2021, 31(2):291-295.
[12] 李宏波, 吴志刚, 徐爱芳. 重症手足口病患儿外周血炎性细胞因子表达与临床意义[J].中华医院感染学杂志, 2015, 25(19):4371-4374.
[13] ESNAULT S, KHOSRAVI M, KELLY E A, et al. Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge[J].Clin Exp Allergy,2021, 51(4):564-573.
[14] 吴文静. 儿科早期预警评分及常见血常规,炎症标志物对危重症手足口病患儿早期诊断的价值[J].标记免疫分析与临床, 2021, 28(3):472-475.